35
Participants
Start Date
April 25, 2023
Primary Completion Date
October 17, 2023
Study Completion Date
October 17, 2023
Observational
"The goal of this observational study is to assess the reliability and validity of the multi-luminance Y-Mobility Test (MLYMT) and multi-luminance shape description test (MLSDT) for evaluation of subjects with severe vision impairment due to RP.~Normally sighted subjects will provide a control group. The MLYMT consists of two LED panels, one of which is illuminated at multiple luminance levels, positioned at the end of Y-configuration. Seven obstacles are placed ahead of the panels, which the test subject should detect and avoid before reaching and touching the lit panel."
Nanoscope Clinical Site, Miami
Nanoscope Clinical Site, Fargo
Nanoscope Clinical Site, Bellaire
Nanoscope Clincal Site, San Antonio
Nanoscope Clinical Site, McAllen
Nanoscope Clinical Site, Phoenix
Nanoscope Clinical Site, Beverly Hills
Nanoscope Clinical Site, Arecibo
Lead Sponsor
Nanoscope Therapeutics Inc.
INDUSTRY